A lower-cost insulin manufacturer has taken the next step toward establishing a location in West Virginia. UNDBIO, a South Korean company, has secured a lease with West Virginia University to build an ...

Pharmaceutical companies layer on patents for drug delivery devices to maintain market exclusivity, according to a new study.

SACRAMENTO — California is diving into the prescription drug business, attempting to achieve what no other state has done: produce its own brand of generic insulin and sell it at below-market prices ...

--(BUSINESS WIRE)--Optum Rx, a pharmacy services company, today announced additional actions to make insulin more affordable, moving several rapid-, short- and long-acting insulins to tier one, which ...

LANSING, Mich. (WLNS) – The Eaton County Board of Commissioners took the first step in suing insulin manufacturers over allegations of price fixing. Commissioner Jacob Toomey tells 6 News a resolution ...

Congress failed to pass a proposal that would have capped out-of-pocket insulin costs at $35 a month for people not covered by Medicare. More than 34 million Americans have diabetes, and it’s ...

MORGANTOWN W.Va. – South Korean drug manufacturer UNDBIO has signed a Memorandum of Understanding pledging to manufacture insulin in West Virginia. The letter indicates there are plans to locate the ...